-
340NewsHKSTP’s Startup BioMap Secured Funding from HKIC for AI and Biotech Development
HONG KONG SAR – Media OutReach Newswire – 24 June 2024 – Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park...
-
377NewsInforma Markets Drives Thai Medical Laboratory and Healthcare Industry Through “Medlab Asia and Asia Health 2024”
BANGKOK, THAILAND – Media OutReach Newswire – 24 June 2024 – Informa Markets Thailand is set to host “Medlab Asia and Asia...
-
332Wire StoriesHighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss
Preclinical results in naturally occurred diabetic monkeys were presented at the American Diabetes Association 84th Scientific Sessions, June 21-24, 2024 HighField plans...
-
595NewsINSPIRE Concert Series ‘Westlife The Hits Tour 2024’ in Korea Rescheduled to November 23, 2024
INCHEON, SOUTH KOREA – Media OutReach Newswire – 24 June 2024 – Mohegan INSPIRE Entertainment Resort (President Chen Si, hereinafter “Mohegan INSPIRE”...
-
376News
Luxshare Precision’s Global Footprint and Scalable Manufacturing Capabilities Strengthen its Position as a Trusted Supplier Amidst Robust Human Rights Protections
HONG KONG SAR – Media OutReach Newswire – 24 June 2024 – Luxshare Precision, a prominent global technology manufacturer, has leveraged its...
-
349NewsXTransfer Attends 2024 Dalian Summer Davos
The Only Chinese Payment Company in the Unicorn Community HONG KONG SAR – Media OutReach Newswire – 24 June 2024 – XTransfer,...
-
441Wire StoriesTrustQuay Viewpoint Rebrands to Quantios Following Successful Merger
LONDON–(BUSINESS WIRE)–TrustQuay Viewpoint, a global SaaS provider to the Wealth, Trust and Corporate services (TCSP) industry has rebranded to Quantios, as the...
-
430Wire StoriesTakeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies
LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the...
-
435NewsChinese Culture and Entertainment Group Yuewen Collaborates with the Eiffel Foundation to Boost Global IP Development
PARIS, FRANCE – Media OutReach Newswire – 24 June 2024 – On the morning of June 21 (local time), the 10th Bonjour...
-
391NewsZJLD Group Convened 2024 Annual General Meeting
Investors Joined the Signature Distillery Tour and Premium Banquet Immersively Exploring Sauce-aroma Baijiu Paired Exquisite Chinese Cuisine HONG KONG SAR – Media...
